Dr. Robert Lizer, from Carle Health, joins Mark Welp to discuss addiction and addiction recovery. In this episode, Dr. Robert Lizer, from Carle Health, joins Mark Welp to discuss addiction and ...
GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...
Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results